{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:49:43Z","timestamp":1787496583157,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.critrevonc.2021.103415","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:22:19Z","timestamp":1625570539000},"page":"103415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Normal tissue tolerance amongst paediatric brain tumour patients- current evidence in proton radiotherapy"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1459-1820","authenticated-orcid":false,"given":"Mikaela","family":"Dell\u2019Oro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michala","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0448-7691","authenticated-orcid":false,"given":"Puthenparampil","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1315-1735","authenticated-orcid":false,"given":"Eva","family":"Bezak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2018.04.016","article-title":"SIOPE \u2013 brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy","volume":"128","author":"Ajithkumar","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2017.06.010","article-title":"Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy","volume":"124","author":"Antonini","year":"2017","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-016-2090-4","article-title":"Pencil beam scanning proton therapy for pediatric intracranial ependymoma","volume":"128","author":"Ares","year":"2016","journal-title":"Neuro-oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0020","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/cancers7020706","article-title":"Dosimetric comparison and potential for improved clinical outcomes of paediatric CNS patients treated with protons or IMRT","volume":"7","author":"Armoogum","year":"2015","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.critrevonc.2021.103415_bib0025","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2021.103415_bib0030","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1667\/RR1903.1","article-title":"Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study","volume":"174","author":"Armstrong","year":"2010","journal-title":"Radiat. Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2021.103415_bib0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1510795","article-title":"Reduction in late mortality among 5-Year survivors of childhood Cancer","volume":"374","author":"Armstrong","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmp.2017.11.013","article-title":"A radiobiological Markov simulation tool for aiding decision making in proton therapy referral","volume":"44","author":"Austin","year":"2017","journal-title":"Phys. Med."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0045","series-title":"Cancer in Adolescents and Young Adults in Australia. Canberra","author":"Australian Institute of Health and Welfare (AIHW)","year":"2018"},{"key":"10.1016\/j.critrevonc.2021.103415_bib0050","first-page":"1","article-title":"Visual decline in pediatric survivors of brain tumors following radiotherapy","author":"Bates","year":"2020","journal-title":"Acta Oncol. (Madr)"},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0055","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1016\/j.ijrobp.2011.01.005","article-title":"On the benefits and risks of proton therapy in pediatric craniopharyngioma","volume":"82","author":"Beltran","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0060","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2014.05.051","article-title":"Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity","volume":"90","author":"Bishop","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0167-8140(93)90184-A","article-title":"Relative biological effectiveness of intermediate energy protons. Comparisons with 60Co gamma-radiation using two cell lines","volume":"28","author":"Blomquist","year":"1993","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0070","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijrobp.2010.11.027","article-title":"Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas","volume":"82","author":"Boehling","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.critrevonc.2021.103415_bib0075","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3109\/0284186X.2011.582514","article-title":"Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma","volume":"50","author":"Brodin","year":"2011","journal-title":"Acta Oncol. (Madr)"},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103415_bib0080","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/0284186X.2013.858824","article-title":"Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: minimizing the life years lost attributable to failure to control the disease and late complication risk","volume":"53","author":"Brodin","year":"2014","journal-title":"Acta Oncol. (Madr)"},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103415_bib0085","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/neuonc\/not225","article-title":"Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique","volume":"16","author":"Brodin","year":"2014","journal-title":"Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijrobp.2018.03.012","article-title":"Estimated IQ systematically underestimates neurocognitive sequelae in irradiated pediatric brain tumor survivors","volume":"101","author":"Burgess","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0095","series-title":"Cancer Council and Childhood Cancers","author":"Cancer Council","year":"2019"},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103415_bib0100","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2007.08.027","article-title":"Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique","volume":"70","author":"Cochran","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clon.2019.01.002","article-title":"Pediatric normal tissue effects in the clinic (PENTEC): an international collaboration to analyse normal tissue radiation dose-volume response relationships for paediatric Cancer patients","volume":"31","author":"Constine","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0110","first-page":"1","article-title":"Pediatric normal tissue effects in the clinic (PENTEC): an international collaboration to assess normal tissue radiation dose-volume-Response relationships for children with Cancer","author":"Constine","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103415_bib0115","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijrobp.2012.12.004","article-title":"Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors","volume":"86","author":"De Amorim Bernstein","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102881","article-title":"Gender-dependent radiotherapy: The next step in personalised medicine?","volume":"147","author":"De Courcy","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2019.03.018","article-title":"Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: current situation, international survey and future perspectives","volume":"114","author":"de Rojas","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103415_bib0135","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0167-8140(17)30552-2","article-title":"SP-0108: new horizons in radiobiology: from Relative Biological Effectiveness to \u201cnew biology\u201d","volume":"123","author":"Durante","year":"2017","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2018.06.036","article-title":"Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours","volume":"130","author":"Dutz","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2021.01.004","article-title":"Modelling of late side-effects following cranial proton beam therapy","volume":"157","author":"Dutz","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fonc.2015.00261","article-title":"Secondary malignancy risk following proton radiation therapy","volume":"5","author":"Eaton","year":"2015","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijrobp.2015.09.014","article-title":"Clinical outcomes among children with standard-risk medulloblastoma treated with proton and photon radiation therapy: a comparison of disease control and overall survival","volume":"94","author":"Eaton","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.critrevonc.2021.103415_bib0160","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/neuonc\/nov302","article-title":"Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma","volume":"18","author":"Eaton","year":"2016","journal-title":"Neuro-oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0170","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11060-017-2597-3","article-title":"Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients","volume":"135","author":"Fortin","year":"2017","journal-title":"J. Neurooncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0175","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jrr\/rrs114","article-title":"Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation","volume":"54","author":"Friedrich","year":"2013","journal-title":"J Radiat Res (Tokyo)."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(98)00092-9","article-title":"Relative biological effectiveness of proton beams in clinical therapy","volume":"50","author":"Gerweck","year":"1999","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijrobp.2015.09.015","article-title":"Incidence of CNS injury for a cohort of 111 patients treated with proton therapy for medulloblastoma: LET and RBE associations for areas of injury","volume":"95","author":"Giantsoudi","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103415_bib0190","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2014.04.053","article-title":"Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas","volume":"89","author":"Greenberger","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103415_bib0195","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/neuonc\/noz070","article-title":"Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients","volume":"21","author":"Gross","year":"2019","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijrobp.2015.05.018","article-title":"Imaging changes in pediatric intracranial ependymoma patients treated with proton beam radiation therapy compared to intensity modulated radiation therapy","volume":"93","author":"Gunther","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2018.01.013","article-title":"National Cancer institute workshop on proton therapy for children: considerations regarding brainstem injury","volume":"101","author":"Haas-Kogan","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.critrevonc.2021.103415_bib0210","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00066-016-1005-9","article-title":"Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma","volume":"192","author":"Harrabi","year":"2016","journal-title":"Strahlenther. Onkol."},{"issue":"8","key":"10.1016\/j.critrevonc.2021.103415_bib0215","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/0284186X.2017.1324207","article-title":"A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma","volume":"56","author":"Ho","year":"2017","journal-title":"Acta Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0220","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2008.01.050","article-title":"Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose","volume":"72","author":"Hua","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0225","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ctrv.2018.10.003","article-title":"Current status of proton therapy outcome for paediatric cancers of the central nervous system \u2013 analysis of the published literature","volume":"70","author":"Huynh","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2019.01.009","article-title":"Are further studies needed to justify the use of proton therapy for paediatric cancers of the central nervous system? A review of current evidence","volume":"133","author":"Huynh","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2021.103415_bib0235","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3109\/0284186X.2014.957414","article-title":"Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy","volume":"53","author":"Indelicato","year":"2014","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103415_bib0240","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/0284186X.2017.1413248","article-title":"Outcomes following proton therapy for pediatric ependymoma","volume":"57","author":"Indelicato","year":"2018","journal-title":"Acta Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0245","doi-asserted-by":"crossref","first-page":"P815","DOI":"10.1016\/j.ijrobp.2021.01.027","article-title":"Proton therapy for pediatric ependymoma: mature results from a bicentric study","volume":"110","author":"Indelicato","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0250","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28941","article-title":"Second tumor risk in children treated with proton therapy","author":"Indelicato","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2021.103415_bib0255","series-title":"ICRU Report 78: Prescribing, Recording, and Reporting Proton-beam Therapy","author":"International Commission on Radiation Units and Measurements (ICRU)","year":"2007"},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103415_bib0260","article-title":"ICRP publication 127: radiological protection in ion beam radiotherapy","volume":"43","author":"International Commission on Radiological Protection (ICRP)","year":"2014","journal-title":"ICRP Publication 127. Ann."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijrobp.2013.05.017","article-title":"Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy","volume":"87","author":"Jimenez","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijrobp.2014.05.054","article-title":"Patterns of failure after proton therapy in medulloblastoma","volume":"90","author":"Jones","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1063","key":"10.1016\/j.critrevonc.2021.103415_bib0275","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160116","article-title":"Why RBE must be a variable and not a constant in proton therapy","volume":"89","author":"Jones","year":"2016","journal-title":"Br. J. Radiol."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103415_bib0280","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0360-3016(00)00781-1","article-title":"Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy","volume":"48","author":"Jones","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"872","key":"10.1016\/j.critrevonc.2021.103415_bib0285","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1259\/bjr.73.872.11026853","article-title":"Proton beam radiotherapy","volume":"73","author":"Jones","year":"2000","journal-title":"Br. J. Radiol."},{"issue":"10","key":"10.1016\/j.critrevonc.2021.103415_bib0290","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.2015.62.1383","article-title":"Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors","volume":"34","author":"Kahalley","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103415_bib0295","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.19.01706","article-title":"Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma","volume":"38","author":"Kahalley","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0300","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/neuonc\/noy124","article-title":"Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age","volume":"21","author":"Kok","year":"2019","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","article-title":"Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus","volume":"128","author":"Lambrecht","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103415_bib0315","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2008.13.5293","article-title":"Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial","volume":"26","author":"Laughton","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0320","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0325","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3340\/jkns.2018.0004","article-title":"Radiation Therapy against Pediatric Malignant Central Nervous System Tumors: Embryonal Tumors and Proton Beam Therapy","volume":"61","author":"Lim","year":"2018","journal-title":"J. Korean Neurosurg. Soc."},{"issue":"11","key":"10.1016\/j.critrevonc.2021.103415_bib0330","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/neuonc\/not121","article-title":"Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients","volume":"15","author":"Macdonald","year":"2013","journal-title":"Neuro-oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103415_bib0335","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijrobp.2007.11.065","article-title":"Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons","volume":"71","author":"MacDonald","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0340","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0345","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ijrobp.2009.08.078","article-title":"Radiation associated brainstem injury","volume":"76","author":"Mayo","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0350","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0355","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pbc.21530","article-title":"Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function","volume":"51","author":"Merchant","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"issue":"36","key":"10.1016\/j.critrevonc.2021.103415_bib0360","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1200\/JCO.2011.37.9453","article-title":"Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors","volume":"29","author":"Merchant","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0365","article-title":"Primary hypothyroidism in childhood Cancer survivors treated with radiation therapy: a PENTEC comprehensive review","author":"Milano","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0370","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13014-014-0220-8","article-title":"Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation","volume":"9","author":"Min","year":"2014","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0375","article-title":"An open invitation to join the Pediatric Proton\/Photon Consortium Registry to standardize data collection in pediatric radiation oncology","author":"Miranda","year":"2020","journal-title":"Br. J. Radiol."},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103415_bib0380","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2176\/nmc.ra.2017-0003","article-title":"Proton beam therapy for pediatric brain tumor","volume":"57","author":"Mizumoto","year":"2017","journal-title":"Neurol Med Chir."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0385","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","author":"National Cancer Institute","year":"2018"},{"issue":"22","key":"10.1016\/j.critrevonc.2021.103415_bib0390","doi-asserted-by":"crossref","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys Med Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0395","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.critrevonc.2021.103415_bib0400","first-page":"1051","article-title":"Radiotherapy and late effects","volume":"67","author":"Palmer","year":"2020","journal-title":"Pediat Clin."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0405","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-015-0441-5","article-title":"Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors","volume":"10","author":"Park","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103415_bib0410","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ijrobp.2009.09.031","article-title":"Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma","volume":"78","author":"Paulino","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0415","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2018.01.002","article-title":"Ototoxicity and cochlear sparing in children with medulloblastoma: proton vs. Photon radiotherapy","volume":"128","author":"Paulino","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0420","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2015.06.012","article-title":"Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors","volume":"93","author":"Pulsifer","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0425","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2018.05.069","article-title":"Cognitive and adaptive outcomes after proton radiation for pediatric patients with brain tumors","volume":"102","author":"Pulsifer","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"74","key":"10.1016\/j.critrevonc.2021.103415_bib0430","first-page":"1","article-title":"Proton radiotherapy for pediatric tumors: review of first clinical results","volume":"40","author":"Rombi","year":"2014","journal-title":"Ital."},{"issue":"6","key":"10.1016\/j.critrevonc.2021.103415_bib0435","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00247-016-3750-4","article-title":"Magnetic resonance imaging patterns of treatment-related toxicity in the pediatric brain: an update and review of the literature","volume":"47","author":"Rossi Espagnet","year":"2017","journal-title":"Pediatr. Radiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0440","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3174\/ajnr.A3219","article-title":"Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy","volume":"34","author":"Sabin","year":"2013","journal-title":"Am J Neuroradiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0445","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2015.01.016","article-title":"Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist\u2019s guide for delineation in everyday practice","volume":"114","author":"Scoccianti","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0450","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmp.2017.04.022","article-title":"Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy","volume":"42","author":"Stokkev\u00e5g","year":"2017","journal-title":"Phys. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2021.103415_bib0455","first-page":"1","article-title":"Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy","volume":"58","author":"Stokkev\u00e5g","year":"2019","journal-title":"Acta Oncol. (Madr)"},{"key":"10.1016\/j.critrevonc.2021.103415_bib0460","first-page":"1","article-title":"Paediatric proton therapy","volume":"92","author":"Thomas","year":"2019","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.critrevonc.2021.103415_bib0465","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2019.08.002","article-title":"Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma","volume":"142","author":"Toussaint","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2021.103415_bib0470","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1080\/0284186X.2019.1639823","article-title":"Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation","volume":"58","author":"Toussaint","year":"2019","journal-title":"Acta Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2021.103415_bib0475","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28465","article-title":"Clinical outcomes and quality of life in children and adolescents with primary brain tumors treated with pencil beam scanning proton therapy","volume":"67","author":"Tran","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"28","key":"10.1016\/j.critrevonc.2021.103415_bib0480","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2018.78.1492","article-title":"Endocrine deficiency As a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors","volume":"36","author":"Vatner","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2021.103415_bib0485","doi-asserted-by":"crossref","DOI":"10.1118\/1.4892930","article-title":"Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans","volume":"41","author":"Wedenberg","year":"2014","journal-title":"Med. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103415_bib0490","first-page":"97","article-title":"Technology insight: proton beam radiotherapy for treatment in pediatric brain tumors. Nature clinical practice","volume":"1","author":"Yock","year":"2004","journal-title":"Oncology"},{"issue":"10","key":"10.1016\/j.critrevonc.2021.103415_bib0495","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3109\/0284186X.2014.957415","article-title":"Protons, the brainstem, and toxicity: ingredients for an emerging dialectic","volume":"53","author":"Yock","year":"2014","journal-title":"Acta Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103415_bib0500","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(15)00167-9","article-title":"Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study","volume":"17","author":"Yock","year":"2016","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103415_bib0505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.prro.2018.12.002","article-title":"Robustness analysis for external beam radiation therapy treatment plans: describing uncertainty scenarios and reporting their dosimetric consequences","volume":"9","author":"Yock","year":"2019","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103415_bib0510","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.radonc.2014.07.003","article-title":"A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation","volume":"113","author":"Zhang","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2021.103415_bib0515","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/cncr.31143","article-title":"Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors","volume":"124","author":"Zureick","year":"2018","journal-title":"Cancer."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:38:58Z","timestamp":1760902738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842821002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":103,"alternative-id":["S1040842821002031"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103415","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normal tissue tolerance amongst paediatric brain tumour patients- current evidence in proton radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103415"}}